Reporting on circulating tumor DNA monitoring in metastatic cancer: From clinical validity to clinical utility

Caroline Brenner Thomsen*, Amanda Dandanell Juul, Anna Cecilie Lefèvre, Christina Glismand Truelsen, Edina Dizdarevic, Heidi Ryssel, Ina Mathilde Kjær, Karen Lycke Wind, Louise Bach Callesen, Louise Faaborg Larsen, Malene Støchkel Frank, Rikke Fredslund Andersen, Karen Lise Garm Spindler, Anders Jakobsen

*Kontaktforfatter

Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

52 Downloads (Pure)

Abstract

This commentary attempts to discuss the required standardization of circulating tumor DNA (ctDNA) analyses and thereby improve the clinical validity of ctDNA monitoring in the metastatic setting of solid tumors.

OriginalsprogEngelsk
TidsskriftCancer
Vol/bind128
Udgave nummer11
Sider (fra-til)2052-2057
ISSN0008-543X
DOI
StatusUdgivet - jun. 2022

Bibliografisk note

Funding Information:
Anna Cecilie Lefèvre, Christina Glismand Truelsen, Karen Lycke Wind, Louise Bach Callesen, and Karen‐Lise Garm Spindler received financial support from The Research Foundation of The Central Denmark Region and The Danish Cancer Society.

Fingeraftryk

Dyk ned i forskningsemnerne om 'Reporting on circulating tumor DNA monitoring in metastatic cancer: From clinical validity to clinical utility'. Sammen danner de et unikt fingeraftryk.

Citationsformater